Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT05619692

Public ClinicalTrials.gov record NCT05619692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.

Study identification

NCT ID
NCT05619692
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
174 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2022 (Actual)
Primary completion
Jun 5, 2024 (Actual)
Completion
Jul 9, 2024 (Actual)
Last update posted
Sep 15, 2025

2022 – 2024

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Sage Investigational Site Gilbert Arizona 85297 —
Sage Investigational Site Phoenix Arizona 85297 —
Sage Investigational Site Lafayette California 94549 —
Sage Investigational Site Long Beach California 90808 —
Sage Investigational Site Redlands California 92374 —
Sage Investigational Site San Diego California 92123 —
Sage Investigational Site Sherman Oaks California 91403 —
Sage Investigational Site Englewood Colorado 80120 —
Sage Investigational Site Hollywood Florida 33024 —
Sage Investigational Site Jacksonville Florida 32256 —
Sage Investigational Site Miami Florida 33155 —
Sage Investigational Site Palm Beach Gardens Florida 33410 —
Sage Investigational Site Pensacola Florida 32504 —
Sage Investigational Site Tampa Florida 33609 —
Sage Investigational Site Winter Park Florida 32789 —
Sage Investigational Site Decatur Georgia 30030 —
Sage Investigational Site Savannah Georgia 31404 —
Sage Investigational Site Honolulu Hawaii 96817 —
Sage Investigational Site Meridian Idaho 83642 —
Sage Investigational Site Chicago Illinois 60640 —
Sage Investigational Site Charlestown Massachusetts 02129 —
Sage Investigational Site Methuen Massachusetts 01844 —
Sage Investigational Site Chesterfield Missouri 63005 —
Sage Investigational Site Papillion Nebraska 68046 —
Sage Investigational Site Toms River New Jersey 08755 —
Sage Investigational Site Albuquerque New Mexico 87109 —
Sage Investigational Site Brooklyn New York 11229 —
Sage Investigational Site Buffalo New York 14203 —
Sage Investigational Site Staten Island New York 10312 —
Sage Investigational Site Raleigh North Carolina 27607 —
Sage Investigational Site Abington Pennsylvania 19001 —
Sage Investigational Site Memphis Tennessee 38119 —
Sage Investigational Site Nashville Tennessee 37212 —
Sage Investigational Site Austin Texas 78731 —
Sage Investigational Site Dallas Texas 75231 —
Sage Investigational Site Houston Texas 77030 —
Sage Investigational Site Fairfax Virginia 22031 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05619692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05619692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →